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Introduction
   The term “epigenetics” is starting to become a 
frequently used term, though it is not yet familiar 
to the general public. Epigenetics is defined as 
“phenomena which regulate gene expression through a 
mechanism other than genome mutation and produce 
changes in cells and the body” [Note 1, 2] (Figure 1).
   The increased use of the term “epigenetics,” a field 
under research, is due to the recent shift in major 
life science research from genome sequencing to the 
understanding of the mechanisms and regulation of 
genomes. Subsequently, people researching translation 
regulation mechanisms, the behavior of chromosomes 
and RNA, genes that cause disease, and development 
and regeneration started to exchange information 
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[NOTE1] : Definition of Epigenetics
The definition of epigenetics is still under debate; however, I will adopt the following definition for this 
report.
*From Purpose of Founding, on The Japanese Society for Epigenetics website: It is known that the 
expression of genetic information, which the genome possesses, is not regulated by only the base 
sequence and transcription apparatus. In organisms, gene expression is also regulated by the chemical 
and structural modification of chromatin, which is composed of genomic DNA and proteins, such as 
histones. These kinds of regulation are called “ epigenetics,” and are established during development 
and are known to work as cellular memory.[2]
For reference, the following is the first stated definition of epigenetics.
* “Changes in genetic function, which is transmitted to offspring and daughter cells, caused by 
mechanisms other than changes in the underlying DNA sequence, and the study therof.”[4]
[NOTE2] : Words Derived from Epigenetics
“Epigenetic” is used as an adjective as opposed to the research area of “epigenetics.” In Japanese, 
“epigenetic” is sometimes used as the name of the research area as well. In addition, “epigenome” means 
epigenetic changes on the genome, and “epigenomics” is the study of epigenomes. “Epigenomic” is the 
adjective.
so as to reveal the mechanisms that regulate genetic 
expression, resulting in a whole new research field. In 
other words, it was as if after putting some pieces of a 
jigsaw puzzle together, researchers started to see the 
big picture of a continent.
    This new continent, called epigenetics, covers many 
areas of research in life sciences, including biological 
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Figure 1 : Epigenetics in Biological Phenomena
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development/differentiation, the effect of pollutants, 
revealing the mechanisms of lifestyle diseases and 
developing drugs for treatment.
   We wrote about epigenetics research in the field 
of cancer research in 2003 in this journal, Trends in 
Science & Technology.[1] This time we decided to 
focus on the trends in epigenetics research once again, 
since epigenetics research has branched into various 
research areas in the past six years and the research 
has advanced to the point where there is a great need 
for international collaboration. Therefore, I will 
introduce recent topics in epigenetics research and 
show the meaning, importance and expectations for 
the future in epigenetics research.
Examples of Epigenetics 
   Identical twins are known to have different body 
features, personalities and preferences, as well as 
differences in the onset of disease and the severity of 
symptoms, despite possessing identical genes. Moreover, 
these differences are small when twins are young and 
increase with age. Also, in the case of cloned animals, 
the exact same fur pattern is not passed down from the 
original animal to the clone, even though their genomes 
are identical. This means that even if a clone of your 
beloved calico can be created, the clone may turn out 
to have bi-colored fur, which does not at all look like 
the calico[5,6] (Figure 2). [Note 3] These are all familiar 
examples of epigenetics.
   In addition, organisms operate strict regulation 
of gene expression, whereby necessary genes of 
the genome are expressed and unnecessary ones 
are terminated, at each step of development and 
differentiation. This regulation of gene expression 
allows cells with identical genomes to differentiate 
into tissues and organs with different shapes and 
functions, such as the heart, lungs and neurons, and 
stay that way in the body for a long time. This is also 
an example of epigenetics.
   Moreover, epigenetics is associated with many 
diseases. Epigenetics is pliable and the condition of 
genetic expression changes in response to external 
stimulation, such as environment and lifestyle as well 
as aging, which may alter healthy genetic expression. 
This is called “epigenetic breakdown” and is deeply 
related to various diseases, including cancer.
[NOTE3] : Color of the Clone’s Fur
When the cat clone was created, the cellular nucleus (derived from the calico) used for nuclear transplant 
was not fully initialized. This suppressed some gene expressions on the X chromosome, where the gene 
that determines the brown color of the fur is located, and as a result, the clone’s fur lacked brown and 
was only bi-colored. However, recent research indicates that fur color and patterns are also influenced 
by the uteral environment during the fetal period as well as by the postnatal nurturing environment (this 
is also epigenetics). However, detailed mechanisms are still unclear, and it will take a little more time to 
create a true “copy animal.”
The genome of this cat clone (right) is identical to that of the calico (left) but the fur 
pattern and personality are different.
Photo courtesy: TAMU College of Veterinary Medicine
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   On the other hand, this pliability is believed to be 
applicable for the treatment of diseases, and basic 
research in epigenetics is underway on how to return 
abnormal gene expression to normal. In addition, 
people involved in regenerative medicine are awaiting 
progress in epigenetics research since more advanced 
knowledge of epigenetics is required to freely 
create (customize) target cells and organs from cells 
possessing pluripotency (cells that can differentiate 
into any tissue or organ), such as ES cells and iPS 
cells.
    Genomic DNA methylation is the most well known 
mechanism for genetic expression, but there are many 
others mechanisms. [Note 4]  Much needs to be clarified 
about the mechanisms, and active investigation is 
underway.
 Epigenetic Research is looming   
   Epigenetics research is blooming, with more 
academic papers being published and activities being 
carried out by the research community.
3-1 Number of Academic Papers on 
Epigenetics
   How much did epigenetic research expand in the 
past 10 years? What is the state of research in Japan 
and throughout the rest of the world?
   In order to answer these questions, I accessed the 
Web of Science, part of the ISI Web of Knowledge 
(THOMSON REUTERS) database, and conducted a 
search, using “epigen*” as the keyword, of the period 
from 2000 to 2008. Research articles (Articles or 
Reviews) published during this period were included 
in the search. I organized secular changes in the 
number of research papers, the number of research 
papers by country, the proportion of research papers 
on various research areas, and the number of research 
papers by research area of the authors’ affiliation into 
graphs using the Analyze Results function of the ISI 
Web of Knowledge.
(1) Changes in the Number of Research Paper 
Publications
    There were 10,110 published research papers in total 
related to epigenetics between 2000 and 2008 (as of 
February 23, 2009). Chronological change shows the 
significant increase in publications following 2004 
(Figure 3).
[NOTE4] : Major Mechanisms of Epigenetic Genetic Expression
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(2) Number of Published Research Papers by Country  
   Research paper publication by country (Figure 
4) shows that the US published the most: close to 
half of the total number of research papers. On the 
other hand, though Japan is second only to the US, it 
publishes only about 10% of the total (1,072 papers), 
which is a similar volume to those of Germany and 
England. 
(3) Proportion of Research Papers on Various 
Research Areas 
   Figure 5 shows the top ten research areas for 
publication in the top four countries of publication 
shown in Figure 4: the US, Japan, England and 
Germany. 
   The result shows that in all four countries, most 
published papers were written by authors working 
in the fields of Biochemistry & Molecular Biology, 
Oncology, Cellular Biology and Genetics. In particular, 
the US and Germany had similar proportions of 
fields with large numbers of publications, including 
Biotechnology & Applied Microbiology, which was 
not seen in Japan or England. On the other hand, 
Oncology had a higher proportion in Japan compared 
to the other three countries, and Biophysics and 
Reproductive Cell Science were the characteristic 
areas found only in Japan. In England, Plant Science 
and Endocrinology & Metabolism were characteristic 
areas. As shown, epigenetics research is covered by a 
wide range of research areas and each country has a 
slightly different portfolio. 
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

 
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   
 
 


  

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

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
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

 
 
Figure 4 : The Number of Research Papers Related to 
Epigenetics by Country
Prepared by the STFC
Figure 5 : Proportion of Research Papers on Various Research Areas by Country (2000–2008)
Prepared by the STFC
*Only the top ten research areas are shown
*Papers that cover more than one research area are counted as one paper in each applicable area, therefore, 
the sum of the proportions may not equal 100%
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(4) Research Institutes in Japan
   Which university/public research organizations in 
Japan are undertaking epigenetics research?
   Table 1 shows the research institutions in which 
the authors of 1072 research papers published 
between 2000 and 2008 belonged to in Japan. 
Among universities, the University of Tokyo, Kyoto 
University and Sapporo Medical University had the 
highest number of publications, and public research 
organizations with high numbers of publications 
included the National Cancer Institute, RIKEN, the 
National Genetic Research Institute and the Aichi 
Prefecture Cancer Center. There were generally no 
regional differences and epigenetic research was 
undertaken by various universities and research 
institutions in all regions.  
3-2  State of Research Community
   The epigenetics research community is becoming 
more active in Western countries and in Japan. The 
following are examples of its activities.
(1) Large Scale Research Conference in 
the US—From the US to International 
Collaborative Projects—
   One example of a large research conference related 
to epigenetics held in the US is the 69th Cold Spring 
Harbour Symposium[Note 5] entitled, “Genome of 
Homosapiens.”[7] The cover of the program was a 
photograph of identical twin girls as if to emphasize 
that epigenetics differs even with the same genome, 
and received much attention from many researchers. 
Though the name of the symposium hints that it targets 
research on humans, most presentations were related 
to epigenetics of yeast, C. elegans, fruit flies, plants 
(Arabidopsis) and mice.
   In addition, Gordon Research Conferences[Note 6]with 
the title of “Epigenetics” have been held every other 
year since 1995. The publicized program of the 2007 
*When authors belong to more than one institution, 
each institution is counted as one. 
Table 1 : The Number of Research Papers by 
Japanese Institutions (2000–2008)
Prepared by the STFC
[NOTE5] : Cold Spring Harbor Symposium
Cold Spring Harbor Laboratory is a world renowned NPO research institute that provides frontier 
research and education in Biology (especially genetics), and is located in Long Island, New York. It has 
produced many Nobel Prize laureates, such as Barbara McClintock (maize transposons). Symposiums on 
the latest research topics have been held there every year since 1933.
[NOTE6] : Gordon Research Conferences
This organization has held research conferences since 1931 to facilitate free discussion and interaction 
for researchers of Biology, Chemistry and Physics. It has international authority and there are different 
section meetings (over 400) for each research topic. The conferences are financed by individual 
participation fees as well as financial support by governments, corporations and financial groups. The 
contents of the meetings are not publicized, and the participants are prohibited from citing contents from 
the meetings in research papers.
Organization to which the authors of the 
paper belong Number of papers
University of Tokyo 117
Kyoto University 91
National Cancer Institute 84
RIKEN 79
Sapporo Medical University 63
Japan Science and Technology Agency 51
Nagoya University 50
Osaka University 46
Kyushu University 44
Tohoku University 44
Tokyo Medical & Dental University 42
Chiba University 35
National Institute of Genetics 35
Okayama University 34
Hiroshima University 29
Gunma University 25
Aichi Cancer Center 24
Hokkaido University 23
Kumamoto University 22
Tottori University 22
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conference shows that there have been reports about 
“epigenome analysis,”[Note7] analyzing which part of the 
genome is causing epigenetics, and epigenetics related 
to human diseases in addition to the traditional main 
reports about gene regulation mechanisms using model 
animals.[8] Another conference is scheduled for August 
2009, with a subtitle of “Role of the Environment 
and Epigenetics on Behavior, Health and Disease,” 
suggesting there may be an increase in research on 
human diseases and the effect of the environment.[9]
    In addition, the “Human Genome Task Force” of the 
American Association for Cancer Research hosted the 
“Human Epigenome Workshop” in 2005 as well as a 
conference with a selected target to plan international 
collaborative projects related to human epigenome 
mapping as a follow up in 2006.[10] At the conference, 
the importance of founding an international group of 
specialists, AHEAD (The Alliance for the Human 
Epigenome and Disease), was discussed. There were 
29 members in the Task Force in 2006, including 
specialists from the US, and European countries such 
as England, Spain and the Netherlands, and from 
Asia including Japan, China, Korea and Singapore. 
Compared to the Human Genome Project, which was 
more centered on Western countries, this group has 
involved Asian countries from the start and has the 
potential to grow into a more international project. 
Since the analysis of epigenomes requires much more 
information compared to that of genomes, it requires 
collaborations involving many countries.
(2) Building a Large Scale Research Network in 
the EU
   The EU founded the Epigenome Network of 
Excellence (NoE) as a part of Framework FP6 (2002–
2006) in 2004 with funding of 12.5M Euros.[11] The 
NoE was founded solely to make academic profit for 
the epigenetics research community by supporting 
academic conferences, workshops, training and shared 
resources. The implementation period is from 2004 to 
2009, however, FP7 (2007–2013) keeps it financially 
supported.
   Recently a huge epigenetics research network was 
formed with the participation of 46 Universities 
and research institutions (83 research groups) from 
12 countries: England, France, Germany, Spain, 
the Netherlands, Belgium, Switzerland, Italy, 
Austria, Croatia, Denmark and Sweden. In addition, 
350 research groups from all over the world are 
participating in on-going research projects of the EU 
through the NoE website.
(3) Epigenetics Research Organizations in Japan
   The Japanese Society for Epigenetics was founded 
in December 2006, and has been hosting annual 
meetings since 2007. The purpose for founding the 
society is as follows.
   Since experimental organisms used in epigenetics 
research vary so widely, from yeast and plants 
to mammals, researchers have been split into 
many different specializations with many different 
conferences (including The Molecular Biology 
Society of Japan, The Japanese Biochemical Society, 
Japanese Cancer Association, Japanese Society of 
Developmental Biologists, The Genetics Society of 
Japan, The Botanical Society of Japan, The Japan 
Society of Human Genetics, The Japanese Society for 
Neurochemistry and Japan Society for Cell Biology). 
The Society was founded to promote communication, 
from the perspective that a place where researchers 
from various societies under the category of 
epigenetics research can gather and exchange 
information is absolutely necessary if progress is to be 
made in the research. (From The Japanese Society for 
Epigenetics website.) [2]
  Moreover, volunteers f rom The Japanese 
Environmental Mutagen Society founded the 
Environmental Epigenomics Society in December 
2008 as a place to discuss various toxicological 
phenomena with epigenetics as the keyword. The 
reason for its foundation was that the importance of 
research in the field of environmental epigenomics 
concerning the correlation between environmental 
factors and genetic expression was starting to be 
recognized in toxicology and clinical medicine.[12]
   In addition, in order to clarify technological 
challenges for the industrial application of epigenetics, 
the New Industry and Industrial Technology 
Development Organization commissioned the 
Japan Biological Informatics Consortium to 
[NOTE7] : Epigenomic Analysis (mapping)
Epigenomic analysis is the analysis of the epigenetic time course and the locus on the genome.
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research “Investigation about the trends in research 
related to epigenetics and challenges for industrial 
application” in 2007, and the report was published 
in February 2008.[3] For this research report, an 
investigation committee consisting of academic-
industrial committee members (including researchers 
representing the epigenetics field) was established, 
and considerations and suggestions were made based 
on lectures and debates held during the committee 
meetings. As a result, technological challenges of 
epigenetics were summarized in seven academic 
and applied areas, and the distance from practical 
application and the future importance were shown for 
each of them (Table 2). In the category of “Distance 
from Practical Application,” there were many listed 
as “(far from practical application)” (10 challenges). 
 
 
 
 
 

 
 
 

 
 
 
 
                 
          ◎  ◎  ○  ○ 
         ◎  ◎  ◎  ◎ 
             
 
◎  ○  ○  ◎ 
            
 
△  ◎  ○  ○ 
         
  
       
               
             
        
△  ◎  ○  ◎ 
       △  ○  ○  ○ 
              
               
 
○  ◎  ○  ◎ 
             
    
○  ◎  ○  ◎ 
              
         
       
○  ◎  ○  ○ 
                   
   
△  ○  ○  ○ 
               
                 
     
◎  ○  ◎  ◎ 
                 
 
△  ○  ○  ○ 
         △  ○  ○  ○ 
               
             
  
◎  ◎  ◎  ◎ 
    ‐    ‐   
      
△  ◎  ○  ◎ 
    ‐         
     
◎  △  △  ○ 
            ‐   
   
△  ○  ○  ○ 
                 
  
○  ○  ○  ◎ 
      △  ◎  △  ○ 
              
       △  ○  ○  ○ 
               
  
○  ◎  ○  ◎ 
Table 2 : Summary of Technical Topics of Epigenetics by NEDO Investigation
Source: Reference[3]
* The topics were given ◎ , ○ or △ based on discussions with the investigation working group and 
the investigation committee, which comprises epigenetics researchers and influential members of 
the Industry and Academic committee.[3]
* ◎ , ○ and △ in the figure indicate the level of positivity. Therefore, regarding “Distance from practical 
application,” ◎ means close, ○ means fairly close and △ means far. With regard to “Future 
importance,” “International competitiveness” and “Necessity of national support,” ◎ means high, ○ 
means fairly high and △ means not very high.
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These are considered as topics in epigenetics that are 
currently at the basic research level. Consequently, 
progress in basic research will bring about a 
breakthrough to the next technological development.
Wh a t  ca n  We  L e a rn  f r o m 
Epigenetics? 
    Here I show what we have learned from epigenetics 
and what we can learn in the future.
4-1   Biological Research of Epigenetics
(1)  Mystery of Mammalian Birth
   One of the great mysteries of Biology is why a 
male and a female are necessary for mammalian 
reproduction. Some insects, fish, reptiles and birds 
are known to reproduce through parthenogenesis, 
the ability to reproduce without fertilization by a 
male; however, mammals only reproduce sexually 
and there have been no reports of naturally-
occurring mammalian parthenogenesis in the wild.
    For mammalian reproduction, genes of both a 
male (sperm) and a female (oocyte) are necessary, 
and though embryos (fertilized egg before the 
formation of placenta) form with only paternal 
genes or maternal genes, development stops before 
the embryo grows into an organism. Actually, a 
normally developed embryo’s paternal and maternal 
genomes have different epigenetic patterns, and 
the combination of these two genomes, which 
differ epigenetically, are known to be necessary for 
mammalian development. This was revealed by a 
report in 2004[13] of two female mice (ova) that bore 
offspring when one of the ova was changed into a 
paternal epigenetic pattern. In the future, research 
will move ahead regarding why mechanisms that 
prevent parthenogenesis developed in mammals.
(2)  Evolution of Mammals
   The methylation of genomic DNA is conserved 
in a wide variety of organisms, including plants, 
insects, fish, birds and mammals, though genomic 
imprinting that differentiates paternal and maternal 
genes is only found in viviparous mammals. This 
means that genomic imprinting is not found in egg 
laying mammals such as the platypus.
    In addition, different types of viviparous 
mammals, including marsupials such as kangaroos 
and koalas, for example, and other types such as 
humans and mice (eutherian), have different genes 
involved in genomic imprinting, which indicates 
that the genes of the common ancestor of marsupials 
and eutherians became involved in genomic 
imprinting after splitting off from the platypus 
in the evolutionary journey, and subsequently 
marsupials and eutherians split away and evolved to 
have their own genomes.[14] As shown, the process 
of mammalian evolution can be traced through 
epigenetic analysis.
(3)  Essence of Plants
   Though I have mainly introduced research on 
animals, epigenetic research on plants (Arabidopsis) 
is also progressing. Since the mutation of genes 
involved in plant epigenetics is not as fatal as it is in 
animals, a variety of morphology (with morphology 
of leaves and pollen different from normal) created 
through gene mutation is being studied in Arabidopsis 
to advance the research. In addition, morning glory, 
rice and wheat are used in research.   
4-2  Research of the Role of Epigenetics in 
Disease
(1) Understanding the Pathogenesis of Cancer
   Since the 1990s there have been many reports 
about the abnormality of the methylation of DNA 
in genes related to multiple cancers in various 
cancerous cells, bringing attention to the relationship 
between epigenetics and the onset of cancer.
   In particular, gastric cancer is believed to be deeply 
related to epigenetics. One of the factors that increase 
the risk of gastric cancer is Helicobacter pylori, 
the infection of which was recently discovered as 
inducing epigenetic mutations.[15] When gene 7 on 
locus 8, known for its DNA methylation in gastric 
cancer, was compared between the gastric mucosa 
of subjects testing positive for H. pylori infection 
and those testing negative, positive subjects had 
methylation increases of 5 to 303 times those of 
negative subjects. In addition, non-cancerous 
mucosa of gastric cancer patients had methylation 
increases of 2 to 32 times those of gastric mucosa of 
healthy subjects. Moreover, the level of methylation 
of specific genes is reported to decrease after the 
eradication of H. pylori, indicating that knowledge 
of epigenetics may be useful for detecting risks of 
and preventing gastric cancer in the future.
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   The types of cancer that can be detected through 
epigenetics include gastric cancer, colon cancer, 
breast cancer and kidney cancer.[16]  
(2) Relationship between the Pathogenesis of 
Mental Disorders and Behavioral Disorders
   Recently, progress has been made in research 
based on the hypothesis that epigenetic breakdown 
is involved in neuropsychiatric disorders and 
neurodevelopmental disorders.
   As for neuropsychiatric diseases,  research includes: 
1) research on the involvement of the epigenetic 
changes (change in histone modification) in the 
mechanisms of the effects of antidepressant and 
electric convulsive treatment, 2) research on the 
relationship between genomic imprinting and bipolar 
disorder, since the symptoms and the age of onset 
differs depending on whether the bipolar disorder is 
paternal or maternal, 3) comparative research on the 
methylation of DNA, which is thought to be related 
to the onset of bipolar disorder and schizophrenia, in 
postmortem brains of patients and the control group, 
and 4) the relationship between the variance of the 
onset of bipolar disorder in identical twins (cases 
where only one of them develops the disorder) and 
DNA methylation.[17] However, such research is all still 
heavily based on estimation, and the involvement of 
epigenetics is still to be clarified.
   Regarding neurodevelopmental disorder, there 
are about nine disorders that are known to have 
congenital abnormality in genes related to epigenetics, 
such as DNA methylation, chromatin remodeling 
(conformational changes of chromatin), histone 
modification and X chromosome inactivation.[18] 
In addition, there was a report in 2004 that showed 
postnatal abuse decreases the gene expression of 
the glucocorticoid receptor due to methylation, 
which subsequently causes behavioral disorders in 
animals,[19] suggesting that epigenetics is involved in 
acquired neurodevelopmental disorders as well.
   In the future, the importance of environmental 
factors on neurodevelopment and behavior will 
be understood based on scientific evidence like 
epigenetics. Furthermore, progress in research in this 
area will bring a great contribution to the prevention 
and treatment of behavioral disorders.
(3) Relationship with Lifestyle Diseases
   Recently a hypothesis arguing that factors leading 
to lifestyle diseases form during the fetal period (Fetal 
Origins of Adult Disease) was introduced.[20] According 
to this hypothesis, exposure to poor nutrition or 
hypernutrition during the critical period of organ 
and metabolic formation in the fetal period induces 
epigenetic changes, such as DNA methylation, and 
disease develops as a result of postnatal hypernutrition 
and little exercise. In addition, the epigenetic changes 
caused by the fetal environment are passed down for 
a few generations. However, these hypotheses are not 
yet proven and the mechanism is still to be clarified.[21]  
    A report in 2005 investigated the effect of exposure 
to poor nutrition in the pregnant mother and normal 
feed to the offspring after birth on genes related to fat 
metabolism in the liver at postnatal day 50 in animals 
(adult). The result showed that DNA methylation was 
decreased and expressions of multiple genes were 
increased 3 to 10 fold, indicating that the effects of 
changes in the fetal environment are still observed in 
adults.[21,22]
   In 2009, a knockout mouse lacking Jhdm2a, a 
gene involved in epigenetics, developed obesity and 
hyperlipidemia.[23]  
   The information above shows there is a number 
of indications that epigenetics is involved in the 
development of adult diseases.
4-3  Drug Development and Epigenetics
   The development of drugs for cancer treatment 
targeting epigenetics is underway. In particular, 
inhibitors of DNA methyltransferase (DNMT) and 
Histone Deacetylase (HDAC) are reported to be 
effective.[Note 8] Table 3 shows that as of May 2009 
there are three epigenetic medicines on the market, 
all approved in the US. In addition, there are drug 
candidates that are going through phase I and II of 
clinical trials in the US that are not listed in the figure 
(Belinostat, MGCD-0103, Panobinostat, Romidepsin).[24]
   Decitabine, a DNMT inhibitor, is reported to be 
more effective when administered at a low dose for 
a long period compared to a high dose for a short 
period.[25] Since DNMT is necessary in healthy 
cells, its inhibitor may cause cell death at high doses 
and there are fewer side effects at lower doses. 
However, the mechanism of the effect of the long- 
term administration of a low dose is still unclear. In 
addition, a clinical trial of combined administration of 
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decitabine and various HDAC inhibitors is underway.
   In Japan, there are not yet any approved epigenetic 
drugs. However, FK228, shown in Table 3, was 
discovered by a researcher at Fujisawa Pharmaceutical 
Co., Ltd (now Astellas Pharma Inc.) during an 
investigation of natural products of fermentation. It 
was subsequently developed into a drug by Gloucester 
Pharmaceutical, Inc., an American anti-cancer drug 
development venture company, which licensed out the 
product.[26]
4-4 Quality Evaluation of iPS cells with 
Epigenetics
   Since stem cells possess the ability to differentiate 
into various types of cells, their application in 
regenerative medicine to regenerate tissues and 
organs damaged by disease has been long awaited. In 
particular, since iPS cells are produced by inserting 
genes into somatic cells, there are few ethical issues 
compared to ES cells produced by a fertilized embryo. 
The technology used for iPS cell generation has 
brought the practical use of regenerative medicine 
a step closer. However, current iPS cell generation 
technology produces inconsistent genetic expression 
signatures, so further technical progress is required 
to produce uniform and high quality iPS cells.[27] This 
inconsistency is caused by the variety of epigenetics of 
the somatic cells used to produce iPS cells.
   Therefore, for practical application of iPS cells in 
clinical settings, the further establishment of methods 
to standardize iPS cells and also an epigenetic quality 
evaluation system to provide safe iPS cells to patients 
is required. For these reasons, the importance of 
research in epigenetics that targets iPS cells will 
increase in the future.
              
‐ 
   
 
 
     
 
  
    
‐‐‐ 
 
   
 
 
     
 
 
   
   
 
   
   
     
 
‐ 
‐  
  
  
 
 ‐ 
    
      
  
 
 
  
    
   
      
  
  
    
     
‐  
  
   
  
 
 
      
  

[NOTE8] : DNMT inhibitor and HDAC inhibitor
DNA methylation of DNA in epigenetics occurs when DNA methyltransferase (DNMT) causes the 
methyl base of S-Adenosyl-L-methionin to transfer to DNA. When DNMT is inhibited methylation 
decreases and genetic expression is induced.
On the other hand, during the acetylation of histone, which activates genetic transcription, the actions 
of histone acetyltransferase (HAT) and histone deacetylase (HDAC) oppose each other. When HDAC is 
inhibited, histone is acetylated and genetic transcription is activated.
As is shown, inhibiting DNMT and HDAC activates genetic expression and genetic transcription, so 
these two types of drugs are expected to possess therapeutic effects on diseases that are caused by 
suppression of genetic expression and transcription.
Table 3 : Current Status of Drug Development Targeting Epigenetics
Prepared by the STFC based on Reference [24, 25]
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4-5  Development of Epigenetics Detection 
Equipment  
   It is important to detect which DNA base sequence 
in the genome have been methylated in order to know 
the epigenetic conditions as well as the diagnostic 
marker for diseases such as cancer in the future. 
However, ordinary genetic tests can not detect 
methylated regions.
   In recent years, various methods have been 
developed to detect methylation. Currently, the most 
well known method is bisulfite sequencing, which 
determines the DNA sequence through bisulfite 
preparation of a DNA fragment to change the base.[28] 
Traditionally, such detection was time consuming; 
however, efficient high speed sequencers are starting 
to make exhaustive methylation analysis possible. For 
example, there has been a report about methylated 
genes of Arabidopsis thaliana detected by shotgun 
sequencing.[29] The size of the Arabidopsis genome is 
around 130 million bases, which is small compared 
to the 3-billion-base human genome. Nevertheless, 
this showed that we are a step closer to analyzing 
methylated genomes in mammals.
   However, detection of other types of epigenetics, 
such as histone modification and genomic imprinting, 
still employ time-consuming traditional methods, 
including the chromatin immunoprecipitation 
method and the FISH method.[30] Therefore, the 
development of new methods and equipment that 
will enable high throughput (quick analysis) and 
hence facilitate the clinical application of epigenetics 
is awaited. In addition, as shown in the previous 
paragraph, equipment for the detection of epigenetics 
at the single cell level is necessary for the epigenetic 
quality evaluation of iPS cells. Therefore, one of the 
most important research areas is the development of 
analytical equipment for epigenetics, considering the 
clinical application of the findings from epigenetics 
research.
P r o g r e s s  o f  E p i g e n e t i c s 
Research in the US and Europe
5-1  The US
   NIH plotted the NIH roadmap in 2002 to promote 
more effective and productive medical research and it 
presented research topics that were the most important 
across the entire NIH (27 institutions).[31] Since then, 
there have been little changes made to the selected 
research topics included in the road map.
    In 2007, epigenetics research was added to the NIH 
road map and project funding of $19 billion over 5 
years starting in January 2008 was provided.[32] The 
funding was implemented to support the research 
community discussed in section 3-2.
   For reference, major epigenetics research programs 
included in the road map as of May 2009 are indicated 
in Table 4.
   In addition, the direction of American epigenetics 
research is rapidly heading toward targeting humans, 
as evidenced by the name of the March 2009 research 
achievement debriefing session related to the NIH 

          
・         
   
・          
 
      
    
          
    
     
     
 
・        
 
    
     
   
・              
   
・               
    
   
   

Table 4 : Major Epigenetic Research Program on NIH Roadmap (May 2009)
Prepared by the STFC
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road map: “Emerging evidence for epigenomics 
changes in human disease.”
5-2  Europe
   Support for epigenetics research in Europe started 
around 2000. A team participation project, EPITRON 
(Epigenetic Treatment of Neoplastic Disease)[33] 
is funded with 10.9M Euros under FP6, and seven 
countries participate, including France. In addition, 
another team project, HEROIC (High Throughput 
Epigenetic Regulatory Organization in Chromatin), 
is funded with 12M Euros also by FP6, and eight 
countries participate, including the Netherlands (2005-
2010).[34] In addition, both projects receive additional, 
ongoing funding under FP7.
5-3  Japan
   The activity of the research community does not 
seem to be reflected in the financial support, as there 
is yet to be a promotion of large projects (collaboration 
of multiple research institutions, etc.) for epigenetics 
in Japan. As a result, the majority of public funding 
goes toward individual research, such as Grant-
in-Aid for Scientific Research. Starting in 2007, 
the “Generation Cycle and Epigenome Network of 
Germline” (Leader: Hiroyuki Sasaki, President of 
National Institute of Genetics) will be conducted for 
5 years as a part of the Specific Area of Research of 
Grant-in-Aid for Scientific Research (approximately 
2.3 billion yen).
   There are some projects that include epigenetics 
as part of their program, for example, the “iPS Cells 
and Biological Function,” of the Sakigake Strategic 
Creative Research Promotion Project by Japan 
Science and Technology Agency (JST). JST has stated 
that “epigenetics is strongly related to cancer research, 
but it is also influential in stem cell research” in their 
G-TeC report published in January 2008 and entitled, 
“Stem Cell Homeostasis.”[35] In addition, they noted 
that they “believe that epigenetics related programs 
will be strongly promoted in Japan following the 
Western countries in the future,” indicating that large 
scale epigenetics research will be funded in the near 
future.
Conclusion—Expectations for 
Epigenetics Research in the 
Future— 
   What determines the outcome of organisms, 
including humans, is a question that has been debated 
since ancient times. Is it nature (genes) or nurture 
(environment), or both? Common sense tells us that 
it is a little bit of both. However, there has been no 
scientific evidence to support this belief.
   As opposed to the genome, which does not change 
over a lifetime, epigenetics is constantly changing, 
right from the moment of fertilization. This means 
that epigenetics adds the two variables of the external 
influence of environment and the passage of time to the 
genetic information of an organism, called the genome.
   Through the Human Genome Project, we became 
familiar with the idea that humans’ future behavior and 
susceptibility to disease is fully determined at birth. 
However, from the perspective of epigenetics, humans 
keep changing in response to external influences, and 
though the base is already determined at birth, the 
details are uncertain and possess much potential.
   Epigenetics research has just begun and future 
progress is eagerly awaited. In particular, both 1) the 
accumulation of scientific knowledge about gene 
expression regulation for biological homeostasis, 
and as a result, 2) the development of technology 
to artificially regulate biological gene expressions 
are highly expected. This may bring about much 
discussion about gene control in society.
   In addition, though I have only briefly touched 
upon it in this paper, epigenetics is known to 
change with the process of aging. Therefore, in the 
future, epigenetics research may contribute to the 
development of treatment for diseases and disorders 
specifically related to the elderly. Also, achievements 
in epigenetics research may help us understand how 
organisms are damaged by their environment or stress 
and how to measure the damage accurately, which 
may help us plan policies to protect us from such 
damage, by improving our lifestyles, for example.
   As shown here, epigenetics is a research area that has 
the full potential for future achievements and is the subject 
of much international attention. Therefore, research on 
epigenetics needs active support in Japan as well. In 
addition, one of the most important research topics is 
the development of analytic equipment for epigenetics.
6
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